Tuesday, May 14, 2013
ChanTest Develops New Cardiotoxicity and Contractility Assay with Human Stem Cell Cardiomyocytes |
| |
Tuesday, April 16, 2013
ChanTest Introduces the CardioChannelGram™ and SaVety Assessment |
| |
Tuesday, April 9, 2013
ChanTest Announces Their Second User Meeting: Partnerships in Drug Discovery |
| |
Tuesday, March 19, 2013
ChanTest Announces a Complimentary Webinar on the Use of the xCELLigence System |
| |
Wednesday, February 6, 2013
BioFocus expands ion channel offering through agreement with ChanTest |
| |
Monday, January 14, 2013
ChanTest goes beyond GLP to become first ion channel and GPCR CRO with cGMP testing capability |
| |
Monday, October 15, 2012
ChanTest announces drug discovery services using the Enamine 3D compound library |
| |
Tuesday, September 18, 2012
ChanTest announces Phase II SBIR grant to optimize cardiomyocyte-based assays |
| |
Friday, August 17, 2012
ChanTest hires Chris Mathes as Chief Commercial Officer |
| |
Monday, December 5, 2011
Roche, ChanTest collaborate for preclinical cardiac safety testing of drug compounds using iCell Cardiomyocytes and xCELLigence RTCA Cardio Instrument |
| |
Monday, Nov. 21, 2011
ChanRx Secures Series A Funding |
| |
Thursday, June 9, 2011
ChanTest Signs Research Collaboration Agreement With the FDA
Goal: To Improve Preclinical Cardiac Risk Assessments |
| |
Wednesday, April 6, 2011
ChanTest Corporation First To Offer New High Throughput Electrophysiology Platform Validated for Both VGICs and LGICs |
| |
Thursday, March 24, 2011
ChanTest Corporation and Molecular Devices, Inc. Sign Cell Line Distribution Agreement |
| |
Thursday, July 15, 2010
Emir Duzic to Head GPCR Assay Services for ChanTest Corporation |
| |
Monday, June 21, 2010
Drug Safety Executive Council Presents: Improved Strategies for Pre-clinical Cardiac Testing |
| |
Thursday, February 04, 2010
ChanTest CEO to Speak on New Pre-Clinical Assays for Predicting Cardiotoxicity at Society of Toxicology Annual Meeting - ChanTest to Host Webinar March 23 |
| |
Thursday, February 04, 2010
ChanTest To Hold Free Webinar on Stem Cell-Derived Human Cardiomyocyte Assays in Cardiac Risk Evaluation |
| |
Sunday, November 11, 2009
Dr. John Mills and Joseph Gentile Join Board of Directors of ChanTest Corporation |
| |
Wednesday, May 06, 2009
ChanTest Awarded $4.8 Million Through the Ohio Third Frontier Research and Commercialization Program |
| |
Tuesday, March 10, 2009
ChanTest to Highlight Expanded Ion Channel and GPCR Services and Cell Lines at ToxExpo, Booth 3056 |
| |
Thursday, February 26, 2009
ChanTest Acquires Applied Cell Sciences |
